Boan Biotech Overview
- Year Founded
-
2013
- Status
-
Public
- Employees
-
690
- Stock Symbol
-
06955
- Share Price
-
$0.40
- (As of Friday Closing)
Boan Biotech General Information
Description
Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. It is focused on developing, manufacturing, and marketing biologics, with a focus on oncology, autoimmune diseases, ophthalmology, and metabolic diseases. The company's drug discovery activities revolve around multiple platforms: Fully Human Antibody Platform, bsAb/msAb/Probody Platform, and ADC Platform. It has commercialized several products, such as Boyounuo, Boyoubei (denosumab injection 60 mg), Boluojia (denosumab injection 120 mg), Boyouping (dulaglutide injection), and Boyoujing; and is actively engaged in the development of other drugs like BA1104 (nivolumab injection), BA1106, BA1302 (an anti-CD228 ADC), etc. Geographically, the company generates maximum revenue from the Chinese mainland.
Contact Information
Website
www.boan-bio.comCorporate Office
- No. 39, Science and Technology Avenue
- High-tech Zone
- Yantai, Shandong
- China
Corporate Office
- No. 39, Science and Technology Avenue
- High-tech Zone
- Yantai, Shandong
- China
Boan Biotech Stock Performance
As of 20-Nov-2026, Boan Biotech’s stock price is $0.40. Its current market cap is $243M with 614M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.40 | $0.40 | $0.31 - $1.44 | $243M | 614M | 1.93M | -$0.02 |
Boan Biotech Financials Summary
As of 30-Jun-2026, Boan Biotech has a trailing 12-month revenue of $89.2M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 322,216 | 699,673 | 710,521 | 1,017,500 |
| Revenue | 89,235 | 109,135 | 101,222 | 87,370 |
| EBITDA | 5,093 | 17,956 | 24,854 | (3,347) |
| Net Income | (13,774) | 993 | 10,200 | (16,873) |
| Total Assets | 597,760 | 589,655 | 390,582 | 327,764 |
| Total Debt | 124,161 | 111,949 | 93,908 | 57,262 |
Boan Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Boan Biotech Patents
Boan Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026189212-A1 | Anti-gd2 antibody and antibody-drug conjugate thereof | Pending | 12-Mar-2025 | ||
| WO-2026171129-A1 | Bispecific antibody targeting egfr and b7h3, and antibody-drug conjugate thereof | Pending | 17-Feb-2025 | ||
| WO-2026039940-A1 | Enhanced dll3-protein-targeting chimeric antigen receptor and mutant, and use thereof | Pending | 19-Aug-2024 | ||
| EP-4803098-A1 | Gipr blocking type antibody and antibody conjugate thereof | Pending | 31-Oct-2023 | ||
| WO-2025092705-A1 | Gipr blocking type antibody and antibody conjugate thereof | Inactive | 31-Oct-2023 | C07K16/2869 |
Boan Biotech Signals
Boan Biotech Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Boan Biotech ESG
Risk Overview
Risk Rating
Updated April, 30, 2024
32.83 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,111
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 425
Rank
Percentile
Boan Biotech FAQs
-
When was Boan Biotech founded?
Boan Biotech was founded in 2013.
-
Where is Boan Biotech headquartered?
Boan Biotech is headquartered in Yantai, China.
-
What is the size of Boan Biotech?
Boan Biotech has 690 total employees.
-
What industry is Boan Biotech in?
Boan Biotech’s primary industry is Drug Discovery.
-
Is Boan Biotech a private or public company?
Boan Biotech is a Public company.
-
What is Boan Biotech’s stock symbol?
The ticker symbol for Boan Biotech is 06955.
-
What is the current stock price of Boan Biotech?
As of 20-Nov-2026 the stock price of Boan Biotech is $0.40.
-
What is the current market cap of Boan Biotech?
The current market capitalization of Boan Biotech is $243M.
-
What is Boan Biotech’s current revenue?
The trailing twelve month revenue for Boan Biotech is $89.2M.
-
What is Boan Biotech’s annual earnings per share (EPS)?
Boan Biotech’s EPS for 12 months was -$0.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process